Bérengère Dadone

Diagnostic value of immunohistochemistry for the detection of the BRAF mutation in primary lung adenocarcinoma Caucasian patients

Marius Ilié, Véronique Hofman, Bérengère Dadone et al. · Annals of Oncology · 2012 · 112 citations

Medicine, Oncology, Pathology +16

Adequately defining tumor cell proportion in tissue samples for molecular testing improves interobserver reproducibility of its assessment

Benoît Lhermitte, C. Egelé, Noëlle Weingertner et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2016 · 49 citations

Medicine, Oncology, Pathology +16

Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases

A. Marsaud, Bérengère Dadone, Damien Ambrosetti et al. · Genes Chromosomes and Cancer · 2015 · 46 citations

Medicine, Molecular Genetics, Oncology +17

The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma

Damien Ambrosetti, Maeva Dufies, Bérengère Dadone et al. · PLoS ONE · 2018 · 44 citations · Full text

Medicine, Cancer Biology, Oncology +17

Association of Oncogenic Mutations in Patients With Advanced Cutaneous Squamous Cell Carcinomas Treated With Cetuximab

Alexandra Picard, Florence Pédeutour, Frédéric Peyrade et al. · JAMA Dermatology · 2017 · 36 citations

Medicine, Dermatology, Oncology +15